(Q51323283)

English

Towards a hit for every target

scientific article published on 20 November 2015

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

Towards a hit for every target (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

author name string

Steve Rees

1

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

Philip Gribbon

2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

Karen Birmingham

3

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

William P Janzen

4

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

Garry Pairaudeau

5

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

publication date

20 November 2015

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

Nature Reviews Drug Discovery

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

15

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

1

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

1-2

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

Impact of high-throughput screening in biomedical research

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2015.19

31 March 2020

Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2015.19

31 March 2020

Shaping a screening file for maximal lead discovery efficiency and effectiveness: elimination of molecular redundancy.

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2015.19

31 March 2020

Opening the lead generation toolbox.

1 reference

https://api.crossref.org/works/10.1038%2FNRD.2015.19

31 March 2020

Identifiers

10.1038/NRD.2015.19

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 April 2018

http://europepmc.org/abstract/MED/26585534

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51323283&oldid=2273163818"